This, in turn, mitigates IR, hepatic steatosis, and inflammatory responses by inhibiting downstream JNK and NF-κB signaling pathways, ameliorates IR, and consequently attenuates hepatic steatosis and inflammatory responses (36). This evidence concerns the gene NFKB1 and Hepatic steatosis.